Beneficial effect of PGI2 on circulating endothelial cells
Endothelial damage is an early event in atherogenesis. Recent data present evidence that the counting of circulating endothelial cells in human peripheral blood may provide reliable information about endothelial integrity. We therefore assessed the influence of PGI2 on the number of circulating endothelial cells in patients suffering from peripheral vascular disease. As cigarette smokers and patients with hyperlipoproteinemia show an increased number of circulating endothelial cells, they were excluded from this investigation. PGI2 causes a certain drop in circulating endothelial cells. In parallel, a prolongation in platelet half-life can be noted. This is most pronounced at a daily duration of infusion between 4 an 12 h. A shorter duration of PGI2 therapy is less effective in reducing circulating endothelial cells. All of the three different doses used, however, were equally effective. Placebo controls were ineffective. These findings indicate that PGI2 might exert a rather long-lasting beneficial action on endothelial integrity and the hemostatic balance.
Key wordscirculatingendothelial cells atherosclerosis prostaglandinI2
Unable to display preview. Download preview PDF.
- 1.Buchanan MR, Bastida E, Aznar-Salatti J, deGroot P (1987) Is the endothelial extracellular matrix thrombogenic or thromboresistant? Effect of preparation and 13-HODE levels. Thromb Haemost 58:206Google Scholar
- 3.Davis JW, Shelton L, Eigenberg DA, Hignite CE (1987) Lack of effect of aspirin on cigarette smoke-induced increase in circulating endothelial cells. Haemostasis 7:66–69Google Scholar
- 6.Hladovec J (1977) Vasotropic drugs—a survey based on a unifying concept of their mechanism of action. Arzneimittel-Forsch 27:1073–1076Google Scholar
- 8.Hladovec J (1978) Circulating endothelial cells as a sign of vessel wall lesions. Physiologia bohemoslav 27:140–144Google Scholar
- 9.McCollum CN, Hawker RJ, Norcott HC, Hail C, Drolc Z, Miller MR (1981) Postoperative platelet accumulation in the lungs: can it be measured in surgical patients and does it matter? Thromb Haemost 46:18Google Scholar
- 11.Mustard JF (1984) Platelets, endothelium and vessel injury. Platelets, Prostaglandin and Cardiovascular Systems. Florence, pp 8–11Google Scholar
- 15.Sinzinger H, Kolbe H, Strobl-Jäger E, Höfer R (1984) A simple and safe technique for sterile autologous platelet labeling using Monovette-vials. Europ J Nucl Med 9:320–322Google Scholar
- 16.Sinzinger H, Fitscha P (1986) The principles and applications of treatment of atherosclerotic lesions with prostaglandins. In: Heyns Adu P (Ed) Applications in Atherosclerosis and Thrombosis. South African Medical Research Council, pp 153–162Google Scholar
- 17.Sinzinger H, Fitscha P (1988) Monitoring of antithrombotic therapy with radiolabeled platelets. Proc Book, Cologne (in press)Google Scholar